Taris Biomedical (US) Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
23
- Latest Deal Type
-
M&A
Taris Biomedical (US) General Information
Description
Developer of targeted new therapies designed for the treatment of difficult-to-treat bladder diseases. The company's system is designed to continuously release drugs in the bladder over weeks to months and is deployed and retrieved using minimally-invasive, in-office procedures, enabling drug release to be tailored to match the needs of each disease.
Contact Information
Website
www.tarisbiomedical.comCorporate Office
- 113 Hartwell Avenue
- Lexington, MA 02421
- United States
Corporate Office
- 113 Hartwell Avenue
- Lexington, MA 02421
- United States
Taris Biomedical (US) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 20-Dec-2019 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 21-Dec-2017 | Completed | Clinical Trials - Phase 2 | |||
| 3. Later Stage VC | 27-Oct-2015 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 02-Apr-2013 | $30.7M | $45.7M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 24-Jun-2009 | $15M | $15M | Completed | Startup |
Taris Biomedical (US) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Taris Biomedical (US) Comparisons
Industry
Financing
Details
Taris Biomedical (US) Competitors (4)
One of Taris Biomedical (US)’s 4 competitors is BBS Nanotechnology, a Formerly VC-backed company based in Debrecen, Hungary.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BBS Nanotechnology | Formerly VC-backed | Debrecen, Hungary | ||||
| NuView Life Sciences | Accelerator/Incubator Backed | Fort Lauderdale, FL | ||||
| Cingulate | Formerly VC-backed | Kansas City, KS | ||||
| Viatar CTC Solutions | Formerly VC-backed | Lowell, MA |
Taris Biomedical (US) Patents
Taris Biomedical (US) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026058217-A1 | Intravesical gemcitabine for use in treating bacillus calmette-guérin (bcg)-naive high-risk non-muscle invasive bladder cancer (hr-nmibc) | Pending | 13-Sep-2024 | ||
| CA-233202-S | Part of stylet for a urinary placement catheter | Active | 22-Mar-2024 | ||
| CA-233200-S | Stylet for a urinary placement catheter | Active | 22-Mar-2024 | ||
| CA-233201-S | Stylet for a urinary placement catheter | Active | 22-Mar-2024 | ||
| WO-2025076007-A1 | Methods of treating high-risk non-muscle invasive bladder cancer unresponsive to bacillus calmette-guérin therapy | Inactive | 02-Oct-2023 | A61K31/7068 |
Taris Biomedical (US) Signals
Taris Biomedical (US) Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bristol-Myers Squibb | Corporation | Minority | ||
| Flagship Pioneering | Venture Capital | Minority | ||
| Flybridge (New York) | Venture Capital | Minority | ||
| Foundation Medical Partners | Corporate Venture Capital | Minority | ||
| Norma Investments | Venture Capital | Minority |
Taris Biomedical (US) FAQs
-
When was Taris Biomedical (US) founded?
Taris Biomedical (US) was founded in 2008.
-
Where is Taris Biomedical (US) headquartered?
Taris Biomedical (US) is headquartered in Lexington, MA.
-
What is the size of Taris Biomedical (US)?
Taris Biomedical (US) has 23 total employees.
-
What industry is Taris Biomedical (US) in?
Taris Biomedical (US)’s primary industry is Drug Delivery.
-
Is Taris Biomedical (US) a private or public company?
Taris Biomedical (US) is a Private company.
-
What is Taris Biomedical (US)’s current revenue?
The current revenue for Taris Biomedical (US) is .
-
How much funding has Taris Biomedical (US) raised over time?
Taris Biomedical (US) has raised $103M.
-
Who are Taris Biomedical (US)’s investors?
Bristol-Myers Squibb, Flagship Pioneering, Flybridge (New York), Foundation Medical Partners, and Norma Investments are 5 of 9 investors who have invested in Taris Biomedical (US).
-
Who are Taris Biomedical (US)’s competitors?
BBS Nanotechnology, NuView Life Sciences, Cingulate, and Viatar CTC Solutions are competitors of Taris Biomedical (US).
-
When was Taris Biomedical (US) acquired?
Taris Biomedical (US) was acquired on 20-Dec-2019.
-
Who acquired Taris Biomedical (US)?
Taris Biomedical (US) was acquired by Johnson & Johnson.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process